Breaking News Instant updates and real-time market news.

BLCM

Bellicum Pharmaceuticals

$6.05

0.22 (3.77%)

16:57
08/07/18
08/07
16:57
08/07/18
16:57

Bellicum Pharmaceuticals files $150M mixed securities shelf

  • 07

    Aug

BLCM Bellicum Pharmaceuticals
$6.05

0.22 (3.77%)

03/14/18
JEFF
03/14/18
NO CHANGE
Target $16
JEFF
Buy
Bellicum clinical hold should lift soon, says Jefferies
Jefferies analyst Biren Amin says Bellicum Pharmaceuticals last night provided an update of its leading prgm BPX-501 with an "encouraging" survival rate at one year in pediatric acute myeloid leukemia patients. For BPX-601, management reported CART cell expansion in one pancreatic cancer patient following rimiducid administration, providing first patient validation of the company's activation switch, Amin tells investors in a post-earnings research note. The analyst notes Bellicum has also responded to FDA including proposed protocol changes. Amin believes the clinical hold should lift soon and keeps a Buy rating on Bellicum Pharmaceuticals with a $16 price target.
04/11/18
WELS
04/11/18
UPGRADE
WELS
Outperform
Bellicum Pharmaceuticals upgraded to Outperform at Wells Fargo
04/12/18
WELS
04/12/18
UPGRADE
Target $23
WELS
Outperform
Wells Fargo upgrades Bellicum to Outperform on lifting of clinical hold
Wells Fargo analyst Jim Birchenough last night upgraded Bellicum Pharmaceuticals to Outperform from Market Perform and raised his price target for the shares to $23 from $6. The shares in premarket trading are up 27% to $8.70 following news that the FDA lifted the clinical hold on studies of BPX-501 in the U.S. Rapid resolution of the clinical hold "substantially de-risks the investment," Birchenough tells investors in a research note. He believes Bellicum's platform for controllable cell therapies is well positioned for therapeutic oncology indications.
04/12/18
CANT
04/12/18
NO CHANGE
Target $18
CANT
Overweight
Bellicum price target raised to $18 from $10 at Cantor Fitzgerald
Cantor Fitzgerald analyst Elemer Piros raised his price target for Bellicum Pharmaceuticals to $18 following the announcement of the FDA's lift of its U.S. clinical hold for BPX-501. The analyst now has increased confidence across the BPX-501 platform. He reiterates an Overweight rating on the shares.

TODAY'S FREE FLY STORIES

MS

Morgan Stanley

$48.32

-0.06 (-0.12%)

16:01
08/20/18
08/20
16:01
08/20/18
16:01
Hot Stocks
Morgan Stanley Energy Partners, Catalyst Energy form strategic partnership »

Investment funds managed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

IO

ION Geophysical

$16.65

0.05 (0.30%)

15:58
08/20/18
08/20
15:58
08/20/18
15:58
Hot Stocks
Breaking Hot Stocks news story on ION Geophysical »

Rajay Bagaria reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTX

Centex

$25.26

1.92 (8.23%)

15:57
08/20/18
08/20
15:57
08/20/18
15:57
Hot Stocks
Breaking Hot Stocks news story on Centex 

Qwest trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:57
08/20/18
08/20
15:57
08/20/18
15:57
Hot Stocks
Breaking Hot Stocks news story  

Qwest trading resumes

PAY

Verifone

$23.04

(0.00%)

15:57
08/20/18
08/20
15:57
08/20/18
15:57
Hot Stocks
Breaking Hot Stocks news story on Verifone 

Verifone trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTU

Chad Therapeutics, Inc.

$25.26

1.925 (8.25%)

15:57
08/20/18
08/20
15:57
08/20/18
15:57
Hot Stocks
Breaking Hot Stocks news story on Chad Therapeutics, Inc. 

Qwest trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PCG

PG&E

$44.80

-0.44 (-0.97%)

, EIX

Edison International

$69.24

-0.62 (-0.89%)

15:56
08/20/18
08/20
15:56
08/20/18
15:56
Periodicals
California plan could let PG&E issue bonds to cover fire damages, Bloomberg says »

California Senator Bill…

PCG

PG&E

$44.80

-0.44 (-0.97%)

EIX

Edison International

$69.24

-0.62 (-0.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

BPY

Brookfield Property

$19.90

-0.19 (-0.95%)

15:55
08/20/18
08/20
15:55
08/20/18
15:55
Options
Brookfield Property put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

VERI

Veritone

$11.25

-0.16 (-1.40%)

15:55
08/20/18
08/20
15:55
08/20/18
15:55
Conference/Events
Veritone to hold a conference call »

Management discusses the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

CBS

CBS

$53.67

0.45 (0.85%)

15:46
08/20/18
08/20
15:46
08/20/18
15:46
Periodicals
Court revives copyright suit against CBS over pre-1972 recordings, Reuters says »

CBS is facing a lawsuit…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

  • 27

    Sep

TSLA

Tesla

$304.35

-0.98 (-0.32%)

15:42
08/20/18
08/20
15:42
08/20/18
15:42
Periodicals
Some Tesla suppliers worry about getting paid, WSJ reports »

Some Tesla suppliers have…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

FIT

Fitbit

$6.02

0.315 (5.52%)

15:37
08/20/18
08/20
15:37
08/20/18
15:37
Hot Stocks
Fitbit announces Fitbit Charge 3 »

Earlier today, Fitbit…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

NDSN

Nordson

$134.72

-0.07 (-0.05%)

15:34
08/20/18
08/20
15:34
08/20/18
15:34
Options
Nordson options imply 7.8% move in share price post-earnings, below median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

GOOG

Alphabet

$1,207.00

7.21 (0.60%)

, GOOGL

Alphabet Class A

$1,222.10

6.6 (0.54%)

15:31
08/20/18
08/20
15:31
08/20/18
15:31
Periodicals
Google, IMAX VR project quietly canceled, Variety reports »

A joint virtual reality…

GOOG

Alphabet

$1,207.00

7.21 (0.60%)

GOOGL

Alphabet Class A

$1,222.10

6.6 (0.54%)

IMAX

Imax

$22.80

0.4 (1.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 22

    Aug

  • 06

    Sep

  • 06

    Sep

  • 18

    Sep

  • 20

    Sep

  • 28

    Oct

STAA

STAAR Surgical

$42.05

1.1 (2.69%)

15:24
08/20/18
08/20
15:24
08/20/18
15:24
Conference/Events
STAAR Surgical management to meet with William Blair »

Meeting to be held in Los…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

  • 22

    Aug

SRI

Stoneridge

$32.61

0.39 (1.21%)

15:23
08/20/18
08/20
15:23
08/20/18
15:23
Hot Stocks
Stoneridge appoints Laurent Borne as Chief Technology Officer »

Stoneridge announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 29

    Oct

  • 06

    Nov

DVA

DaVita

$72.44

-0.05 (-0.07%)

15:22
08/20/18
08/20
15:22
08/20/18
15:22
Conference/Events
DaVita management to meet with William Blair »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

ALTR

Altair

$40.63

0.4 (0.99%)

15:20
08/20/18
08/20
15:20
08/20/18
15:20
Conference/Events
Altair management to meet with William Blair »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 22

    Aug

  • 12

    Sep

CBOE

Cboe Global Markets

$98.72

2.96 (3.09%)

15:20
08/20/18
08/20
15:20
08/20/18
15:20
Options
Sweep buyer of CBOE calls »

Sweep buyer of CBOE…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FANH

Fanhua

$25.76

0.53 (2.10%)

15:19
08/20/18
08/20
15:19
08/20/18
15:19
Options
Fanhua options imply 7.4% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
08/20/18
08/20
15:17
08/20/18
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
08/20/18
08/20
15:16
08/20/18
15:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XRAY

Dentsply Sirona

$38.84

0.17 (0.44%)

15:12
08/20/18
08/20
15:12
08/20/18
15:12
Conference/Events
Dentsply Sirona management to meet with William Blair »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 27

    Sep

  • 06

    Nov

STZ

Constellation Brands, also tag STZ.B

$202.74

-1.16 (-0.57%)

15:11
08/20/18
08/20
15:11
08/20/18
15:11
Options
Repeat call spreads in Constellation Brands »

Repeat call spreads in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

LCI

Lannett

$5.43

-8.075 (-59.81%)

, AMRX

Amneal Pharmaceuticals

$23.86

2.33 (10.82%)

15:08
08/20/18
08/20
15:08
08/20/18
15:08
Recommendations
Lannett, Amneal Pharmaceuticals analyst commentary  »

Lannett price target…

LCI

Lannett

$5.43

-8.075 (-59.81%)

AMRX

Amneal Pharmaceuticals

$23.86

2.33 (10.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

  • 28

    Aug

  • 05

    Sep

  • 12

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.